Skip to main content
Equibles

Roger Song

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Roger Song

Roger Song is recorded as Analyst at Jefferies. Roger Song has spoken on 18 earnings calls and 22 other investor events across 29 companies, most recently for UNITED THERAPEUTICS Corp on August 5, 2026. Those appearances were for UNITED THERAPEUTICS Corp (UTHR), Krystal Biotech, Inc. (KRYS), Altimmune, Inc. (ALT), Alx Oncology Holdings Inc (ALXO), Viking Therapeutics, Inc. (VKTX) and 24 other companies. The companies whose calls Roger Song spoke on are classified in the Healthcare sector.

Roger Song on recent calls

“Also along the line, in terms of those new product launch, appreciating the 2027 guidance reaffirmation, how should we think about the launch ramp up for those new products, including the nebulizer IPF, type-based IPF, and then runnopag and Tresmai.”
Analyst — Jefferies, UNITED THERAPEUTICS Corp Q2 FY2026 Earnings Call ·
“For the maintenance study, do you implement a forced titration schedule during the induction period, or do you allow slower titration as long as the patient gets to the target dose?”
Analyst — Jefferies, Viking Therapeutics Q2 2026 Earnings Call and Webcast ·
“Maybe I'll move on to the PD marker for the serine calcium. Very helpful, you give us the peak trough ratio and the differences. Just want to clarify, this is 0.59.”
Analyst — Jefferies, MBX Virtual Investor Event: Once-Weekly Canvuparatide Presentations at ENDO 2026 ·
“It is my pleasure to have the five-side chat with BioAge Labs. And then we have CBO, BJ, and the CFO, Dov, here. Welcome, gentlemen.”
Analyst — Jefferies, Jefferies Global Healthcare Conference ·

Affiliation history

  • Jefferies

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 28 earlier activities